AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechnologies for approximately $1.2bn.

Feb 24, 2024 - 18:00

AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechnologies for approximately $1.2bn.

Read the original article

Tags:

Previous Article

NICE recommends Pfizer’s Ritlecitinib for alopecia areata treatment

AbbVie and Tentarix enter biologic development deal

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Listen: Housing is health care

Listen: Housing is health care

Aug 29, 2023

Opinion: Filling 12-month prescriptions is one practical way to help the pharmacist crisis

Opinion: Filling 12-month prescriptions is one practica...

Nov 21, 2023

STAT+: FDA panel votes against high blood pressure device from Medtronic, but lends support to ReCor Medical’s

STAT+: FDA panel votes against high blood pressure devi...

Aug 23, 2023